In the past few years, the united kingdom has witnessed a revolution in healthcare bodyweight‑reduction treatment options — from your introduction of semaglutide (Wegovy®) into the increasing acceptance of tirzepatide (Mounjaro®). Now, A different identify is drawing attention in equally clinical